• Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
  • Log In
    • Register
Contacts us @ MediPr.org
Medical News Asia | Powered by ['mediPr]
  • MDnews
  • About [‘mediPr]
  • HER2 Explorer
  • TROP Tool
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Scroll to next section Scroll to next section

Non-Sponsored Content


INFECTIOUS DISEASE

Monkeypox Virus: How Likely is a Local Outbreak?

Medical writer: Christy Leung | Last updated: 30 May 2022 | In: Infectious Disease

Article Keywords

orthopoxvirus, tecovirimat, vaccination, monkeypox, smallpox

Just two years after Coronavirus Disease 2019 (COVID-19) emerged, global communities are now concerned about a recent monkeypox outbreak. Monkeypox is a virus which, like smallpox, belongs to the Orthopoxvirus genus.11. Centers for Disease Control and Prevention. About Monkeypox. Available at: https://www.cdc.gov/poxvirus/monkeypox/about.html#:~:text=Monkeypox%20virus%20belongs%20to%20the,vaccine)%2C%20and%20cowpox%20virus.  (Accessed 25 May 2022). Wild animals, such as monkeys and rodents, are its reservoirs; humans can acquire the virus by direct contact with infected animals, respiratory droplets, or body fluid transmission.22. Centre for Health Protection, HKSAR Department of Health. Monkeypox. Available at: https://www.chp.gov.hk/en/healthtopics/content/24/101721.html (Accessed 25 May 2022). Monkeypox is diagnosed by obtaining skin lesion scrapings for electron microscope visualisation and lesion fluid for viral PCR.33. Erez et al. Emerg Infect Dis. 2019;25(5):980–3. It has an incubation period of less than two weeks44. Nolen et al. Emerg Infect Dis. 2016;22(6):1014–21., then presents with systemic signs (fever, chills, sweats), lymphadenopathy, and characteristically sequential skin rash – first macular, then papular, vesicular, and scabbing within two weeks.2,5,62. Centre for Health Protection, HKSAR Department of Health. Monkeypox. Available at: https://www.chp.gov.hk/en/healthtopics/content/24/101721.html (Accessed 25 May 2022).
5. Ligon. Semin Pediatr Infect Dis. 2004;15(4):280–7.
6. Sejvar et al. J Infect Dis. 2004;190:1833–40.
 Most cases are self-limiting and last two to three weeks22. Centre for Health Protection, HKSAR Department of Health. Monkeypox. Available at: https://www.chp.gov.hk/en/healthtopics/content/24/101721.html (Accessed 25 May 2022).; treatment is therefore mostly supportive.77. Reynolds et al. Viruses. 2017; 9(12): 380. 

Monkeypox was first isolated from monkeys in 1958, but it was not until 1970 that the first case in humans was reported.88. Cho et al. Bacteriol Rev. 1973;37(1):1-18 Since then, monkeypox has become endemic in Central Africa, particularly the Democratic Republic of Congo (DR Congo) where the case fatality rate (CFR) is 10.6%.1,91. Centers for Disease Control and Prevention. About Monkeypox. Available at: https://www.cdc.gov/poxvirus/monkeypox/about.html#:~:text=Monkeypox%20virus%20belongs%20to%20the,vaccine)%2C%20and%20cowpox%20virus.  (Accessed 25 May 2022).
9. Bunge et al. PLoS Negl Trop Dis. 2022. doi: 10.1371/journal.pntd.0010141.
 Outbreaks outside Africa are rare but occurred in 2003 and 2022; it is postulated that cessation of smallpox vaccine administration, which could provide cross-protection against monkeypox, increased the likelihood of monkeypox outbreak.6,106. Sejvar et al. J Infect Dis. 2004;190:1833–40.
10. Grant et al. Bull World Health Organ. 2020;98(9):638–40.
 In just 10 days since 13th May, 2022, the World Health Organization (WHO) has already been notified of over 250 laboratory-confirmed cases and suspected cases from 16 countries in Europe, North America, and Australia.11,1211. World Health Organization. Multi-country monkeypox outbreak in non-endemic countries. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON385 (Accessed 25 May 2022).
12. United Nations: UN News. Monkeypox outbreak can still be contained, insists UN health agency. Available at: https://news.un.org/en/story/2022/05/1118882 (Accessed 25 May 2022).
 Alarmingly, infected individuals denied any recent travel to Central Africa, unlike past cases.11,1311. World Health Organization. Multi-country monkeypox outbreak in non-endemic countries. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON385 (Accessed 25 May 2022).
13. The Washington Post. Expert: Monkeypox likely spread by sex at 2 raves in Europe. Available at: https://www.washingtonpost.com/world/expert-monkeypox-likely-spread-by-sex-at-2-raves-in-europe/2022/05/23/fdef8d88-da79-11ec-bc35-a91d0a94923b_story.html (Accessed 25 May 2022).
 The surge of cases calls for immediate actions to halt the further spread.

Although no local cases of monkeypox have been reported in Hong Kong, inbound monkeypox-infected travellers pose a threat as they may initiate a local transmission chain.1414. South China Morning Post. Hong Kong health authorities warn doctors to stay alert for suspected monkeypox cases. Available at: https://www.scmp.com/news/hong-kong/health-environment/article/3178860/hong-kong-health-authorities-warns-doctors-stay (Accessed 25 May 2022).  Hong Kong has halted its smallpox vaccination program since WHO’s declaration of smallpox eradication in 198015,1615. World Health Organization. Smallpox. Available at: https://www.who.int/health-topics/smallpox#tab=tab_1 (Accessed 25 May 2022).
16. Chan-Yeung. Hong Kong Med J. 2017;23(6).
, thus waning immunity against smallpox as observed in other countries is also a risk factor for a monkeypox outbreak in the territories.1717. The Guardian. Why are monkeypox cases suddenly emerging across the world and could the virus have mutated?. Available at: https://www.theguardian.com/world/2022/may/24/why-are-monkeypox-cases-suddenly-emerging-across-the-world-and-could-the-virus-have-mutated (Accessed 25 May 2022). Should an outbreak occur, patient specimens will be obtained to determine the circulating monkeypox strain, since the CFR values of Central African and West African strains differ significantly (10% vs 1%-3.6%), implying contrasting prognoses.

As a developed region, Hong Kong is equipped with sufficient supportive facilities, isolation facilities and personal protective equipment.1818. RTHK News. ‘Risk of monkeypox arriving in HK relatively low’. Available at: https://news.rthk.hk/rthk/en/component/k2/1649664-20220522.htm?spTabChangeable=0 (Accessed 25 May 2022). Furthermore, nosocomial monkeypox transmission is unlikely In healthcare professionals as monkeypox are not as easily transmissible compared to airborne diseases such as COVID-19 and personal protective equipment is sufficient to break transmission chains. Monkeypox has a low mutation rate and is of stable transmissibility19,2019. Duffy. PLOS Biol. 2018;16(8):e3000003.
20. BBC News. Monkeypox virus outbreaks are containable – WHO. Available at: https://www.bbc.com/news/health-61553822 (Accessed 25 May 2022).
, as reassured by the WHO Smallpox Secretariat. Even if there are imported monkeypox cases, the number is expected to be “containable”.2121. World Health Organization. Monkeypox – United Kingdom of Great Britain and Northern Ireland. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON383 (Accessed 25 May 2022). 

Nonetheless, efforts should be made to safeguard public health against monkeypox. Prevention relies on public health education; timely detection of local monkeypox transmission chain requires surveillance by private and public sexual health, red ribbon and dermatology clinics since clinics are likely MSM’s first point of contact and HIV is epidemiologically prevalent in MSM.22,2322. Aids Concern. Men who have Sex with Men (MSM) Team. Available at: https://aidsconcern.org.hk/en/services/team-msm/ (Accessed 25 May 2022).
23. NIH National Library of Medicine: PubChem. Tecovirimat. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Tecovirimat (Accessed 25 May 2022).
Any suspected case should be reported to the Hong Kong Centre for Health Protection.1111. World Health Organization. Multi-country monkeypox outbreak in non-endemic countries. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON385 (Accessed 25 May 2022). Tecovirimat, an orthopoxviral vp37 envelope wrapping protein inhibitor2020. BBC News. Monkeypox virus outbreaks are containable – WHO. Available at: https://www.bbc.com/news/health-61553822 (Accessed 25 May 2022).,  may be useful for monkeypox treatment according to primate studies but lacks corresponding in-human data from clinical studies.2424. Grosenbach et al. New England Journal of Medicine. 2018;379(1):44–53. Future direction may include a restart of the vaccination programme and human clinical trials on tecovirimat, should monkeypox becomes a pandemic.

Reference

  1. Centers for Disease Control and Prevention. About Monkeypox. Available at: https://www.cdc.gov/poxvirus/monkeypox/about.html#:~:text=Monkeypox%20virus%20belongs%20to%20the,vaccine)%2C%20and%20cowpox%20virus. (Accessed 25 May 2022).
  2. Centre for Health Protection, HKSAR Department of Health. Monkeypox. Available at: https://www.chp.gov.hk/en/healthtopics/content/24/101721.html (Accessed 25 May 2022).
  3. Erez et al. Emerg Infect Dis. 2019;25(5):980–3.
  4. Nolen et al. Emerg Infect Dis. 2016;22(6):1014–21.
  5. Semin Pediatr Infect Dis. 2004;15(4):280–7.
  6. Sejvar et al. J Infect Dis. 2004;190:1833–40.
  7. Reynolds et al. Viruses. 2017; 9(12): 380.
  8. Cho et al. Bacteriol Rev. 1973;37(1):1-18.
  9. Bunge et al. PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0010141.
  10. Grant et al. Bull World Health Organ. 2020;98(9):638–40.
  11. World Health Organization. Multi-country monkeypox outbreak in non-endemic countries. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON385 (Accessed 25 May 2022).
  12. United Nations: UN News. Monkeypox outbreak can still be contained, insists UN health agency. Available at: https://news.un.org/en/story/2022/05/1118882 (Accessed 25 May 2022).
  13. The Washington Post. Expert: Monkeypox likely spread by sex at 2 raves in Europe. Available at: https://www.washingtonpost.com/world/expert-monkeypox-likely-spread-by-sex-at-2-raves-in-europe/2022/05/23/fdef8d88-da79-11ec-bc35-a91d0a94923b_story.html (Accessed 25 May 2022).
  14. South China Morning Post. Hong Kong health authorities warn doctors to stay alert for suspected monkeypox cases. Available at: https://www.scmp.com/news/hong-kong/health-environment/article/3178860/hong-kong-health-authorities-warns-doctors-stay (Accessed 25 May 2022).
  15. World Health Organization. Smallpox. Available at: https://www.who.int/health-topics/smallpox#tab=tab_1 (Accessed 25 May 2022).
  16. Chan-Yeung. Hong Kong Med J. 2017;23(6).
  17. The Guardian. Why are monkeypox cases suddenly emerging across the world and could the virus have mutated?. Available at: https://www.theguardian.com/world/2022/may/24/why-are-monkeypox-cases-suddenly-emerging-across-the-world-and-could-the-virus-have-mutated (Accessed 25 May 2022).
  18. RTHK News. ‘Risk of monkeypox arriving in HK relatively low’. Available at: https://news.rthk.hk/rthk/en/component/k2/1649664-20220522.htm?spTabChangeable=0 (Accessed 25 May 2022).
  19. PLOS Biol. 2018;16(8):e3000003.
  20. BBC News. Monkeypox virus outbreaks are containable – WHO. Available at: https://www.bbc.com/news/health-61553822 (Accessed 25 May 2022).
  21. World Health Organization. Monkeypox – United Kingdom of Great Britain and Northern Ireland. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON383 (Accessed 25 May 2022).
  22. Aids Concern. Men who have Sex with Men (MSM) Team. Available at: https://aidsconcern.org.hk/en/services/team-msm/ (Accessed 25 May 2022).
  23. NIH National Library of Medicine: PubChem. Tecovirimat. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Tecovirimat (Accessed 25 May 2022).
  24. Grosenbach et al. New England Journal of Medicine. 2018;379(1):44–53.

YOU MAY ALSO LIKE

MPR-FOS-2023019 HKMA HKSID Launch 4 MAR

Achieving the Best Outcomes under COVID-19 Endemicity

https://www.medi-paper.com/wp-content/uploads/2023/05/MPR-FOS-2023019-HKMA-HKSID-Launch-4-MAR-scaled.jpg 1366 2560 Jeffrey Martin https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Jeffrey Martin2023-05-17 12:25:412023-05-31 12:39:03Achieving the Best Outcomes under COVID-19 Endemicity
INACTIVATED AND mRNA COVID-19 VACCINES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES – A CITY OF TWO TALES

Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales

https://www.medi-paper.com/wp-content/uploads/2023/01/INACTIVATED-AND-mRNA-COVID-19-VACCINES-IN-PATIENTS-WITH-AUTOIMMUNE-RHEUMATIC-DISEASES-–-A-CITY-OF-TWO-TALES.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2023-01-30 10:47:542023-02-02 16:50:53Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales
Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases

Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases

https://www.medi-paper.com/wp-content/uploads/2023/01/Late-but-sinister-post-COVID-19-conditions_new-onset-rheumatic-diseases.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2023-01-16 12:18:572023-03-08 12:48:36Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases
COVID-19 Infection and Subfertility: A Subtle and Debatable Complication

COVID-19 Infection and Subfertility: A Subtle and Debatable Complication

https://www.medi-paper.com/wp-content/uploads/2023/01/COVID-19-Infection-and-Subfertility-A-Subtle-and-Debatable-Complication.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2023-01-16 11:32:342023-01-19 18:28:49COVID-19 Infection and Subfertility: A Subtle and Debatable Complication
Previous Previous Previous Next Next Next
MPR-FOS-2023019 HKMA HKSID Launch 4 MAR
17 May 2023

Achieving the Best Outcomes under COVID-19 Endemicity

INACTIVATED AND mRNA COVID-19 VACCINES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES – A CITY OF TWO TALES
30 January 2023

Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales

Disclaimer

This article is not medical advice. Patients should seek personal assessment by a licenced specialist. Physicians are recommended to read the full publication(s) as cited in the article before making medical decisions. This article does not supersede nor replace the published article(s).

© Copyright 2022 MediPaper Medical Communications Ltd. – Monkeypox Virus: How Likely is a Local Outbreak?

YOU MAY ALSO LIKE

MPR-FOS-2023019 HKMA HKSID Launch 4 MAR

Achieving the Best Outcomes under COVID-19 Endemicity

https://www.medi-paper.com/wp-content/uploads/2023/05/MPR-FOS-2023019-HKMA-HKSID-Launch-4-MAR-scaled.jpg 1366 2560 Jeffrey Martin https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Jeffrey Martin2023-05-17 12:25:412023-05-31 12:39:03Achieving the Best Outcomes under COVID-19 Endemicity
INACTIVATED AND mRNA COVID-19 VACCINES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES – A CITY OF TWO TALES

Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales

https://www.medi-paper.com/wp-content/uploads/2023/01/INACTIVATED-AND-mRNA-COVID-19-VACCINES-IN-PATIENTS-WITH-AUTOIMMUNE-RHEUMATIC-DISEASES-–-A-CITY-OF-TWO-TALES.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2023-01-30 10:47:542023-02-02 16:50:53Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales
Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases

Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases

https://www.medi-paper.com/wp-content/uploads/2023/01/Late-but-sinister-post-COVID-19-conditions_new-onset-rheumatic-diseases.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2023-01-16 12:18:572023-03-08 12:48:36Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases
COVID-19 Infection and Subfertility: A Subtle and Debatable Complication

COVID-19 Infection and Subfertility: A Subtle and Debatable Complication

https://www.medi-paper.com/wp-content/uploads/2023/01/COVID-19-Infection-and-Subfertility-A-Subtle-and-Debatable-Complication.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2023-01-16 11:32:342023-01-19 18:28:49COVID-19 Infection and Subfertility: A Subtle and Debatable Complication
COVID-19 vaccine booster strategy: Striving for the best

COVID-19 VACCINE BOOSTER STRATEGY: STRIVING FOR THE BEST

https://www.medi-paper.com/wp-content/uploads/2023/01/COVID-19-vaccine-booster-strategy_Striving-for-the-best.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2023-01-16 10:03:242024-04-10 14:28:47COVID-19 VACCINE BOOSTER STRATEGY: STRIVING FOR THE BEST
Protection is Never Premature_Maternal COVID-19 Infection and Adverse Perinatal Outcomes

Protection is Never Premature: Maternal COVID-19 Infection is Associated with Adverse Perinatal Outcomes

https://www.medi-paper.com/wp-content/uploads/2022/12/Protection-is-Never-Premature_Maternal-COVID-19-Infection-and-Adverse-Perinatal-Outcomes.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-12-05 11:58:442023-03-08 12:42:36Protection is Never Premature: Maternal COVID-19 Infection is Associated with Adverse Perinatal Outcomes

Updates on COVID-19 Vaccine Booster in Omicron Era

https://www.medi-paper.com/wp-content/uploads/2022/12/Updates-on-COVID-19-Vaccine-Booster-in-Omicron-Era_A.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-12-05 10:59:142022-12-06 15:49:40Updates on COVID-19 Vaccine Booster in Omicron Era
Should your child receive covid-19 vaccination? Risk-benefit analyses in infants, children, and adolescents

Should your child receive covid-19 vaccination? Risk-benefit analyses in infants, children, and adolescents

https://www.medi-paper.com/wp-content/uploads/2022/11/Should-your-child-receive-covid-19-vaccination.-Risk-benefit-analyses-in-infants-children-and-adolescents.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-11-07 02:14:052022-11-09 03:12:41Should your child receive covid-19 vaccination? Risk-benefit analyses in infants, children, and adolescents
At the Heart of the Discussion: COVID-19 Cardiovascular Complications in the Pregnant Women

At the Heart of the Discussion: COVID-19 Cardiovascular Complications in Pregnant Women

https://www.medi-paper.com/wp-content/uploads/2022/11/At-the-Heart-of-the-Discussion.-COVID-19-Cardiovascular-Complications-in-the-Pregnant-Women.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-11-06 07:53:422022-11-07 08:56:16At the Heart of the Discussion: COVID-19 Cardiovascular Complications in Pregnant Women
Covid-19 vaccination safety and effectiveness for pregnant and lactating women

Covid-19 vaccination safety and effectiveness for pregnant and lactating women

https://www.medi-paper.com/wp-content/uploads/2022/10/Covid-19-vaccination-safety-and-effectiveness-for-pregnant-and-lactating-women.jpg 1024 1918 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2022-10-25 06:03:462022-10-25 07:52:49Covid-19 vaccination safety and effectiveness for pregnant and lactating women
Dr Ho SO – Vaccination Safety and Effectiveness in Immunocompromised Patients

HKMA CME Live Lecture: Dr Ho SO – Vaccination Safety and Effectiveness in Immunocompromised Patients

https://www.medi-paper.com/wp-content/uploads/2022/08/Dr-Ho-SO-–-Vaccination-Safety-and-Effectiveness-in-Immunocompromised-Patients.jpg 1024 1918 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2022-08-26 05:25:062022-09-19 11:29:45HKMA CME Live Lecture: Dr Ho SO – Vaccination Safety and Effectiveness in Immunocompromised Patients
Vaccination versus Active Infection_A Comparison of the Cardiovascular Risks

Vaccination versus Active Infection: A Comparison of the Cardiovascular Risks

https://www.medi-paper.com/wp-content/uploads/2022/08/Vaccination-versus-Active-Infection_A-Comparison-of-the-Cardiovascular-Risks.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-08-26 03:30:452022-08-30 10:51:31Vaccination versus Active Infection: A Comparison of the Cardiovascular Risks
Common Respiratory Viruses and Their Associated Cardiovascular Risks

Common Respiratory Viruses and Their Associated Cardiovascular Risks

https://www.medi-paper.com/wp-content/uploads/2022/08/Common-Respiratory-Viruses-and-Their-Associated-Cardiovascular-Risks.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-08-26 02:02:012022-08-30 10:51:35Common Respiratory Viruses and Their Associated Cardiovascular Risks
Strategy for COVID-19 vaccination: Disease control, elimination or eradication

Strategy for COVID-19 vaccination: Disease control, elimination or eradication?

https://www.medi-paper.com/wp-content/uploads/2022/07/Strategy-for-COVID-19-vaccination-Disease-control-elimination-or-eradication.jpg 1024 1918 Kathlin Ambrose https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kathlin Ambrose2022-07-12 07:00:302022-07-13 05:40:30Strategy for COVID-19 vaccination: Disease control, elimination or eradication?
SARS-CoV-2 evolution in the COVID-19 era: Three years and counting

SARS-CoV-2 evolution in the COVID-19 era: Three years and counting

https://www.medi-paper.com/wp-content/uploads/2022/07/SARS-CoV-2-evolution-in-the-COVID-19-era-Three-years-and-counting.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-07-08 08:39:322022-07-12 09:20:40SARS-CoV-2 evolution in the COVID-19 era: Three years and counting
UK statistics suggest COVID-19 variant types as “long COVID” progression predictors

UK statistics suggest COVID-19 variant types as “long COVID” progression predictors

https://www.medi-paper.com/wp-content/uploads/2022/07/UK-statistics-suggest-COVID-19-variant-types-as-long-COVID-progression-predictors.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-07-08 08:01:272022-07-12 09:10:35UK statistics suggest COVID-19 variant types as “long COVID” progression predictors
COVID-19 ANTIVIRAL TREATMENT AND BOOSTER VACCINE EFFECTIVENESS

COVID-19 Antiviral Treatment and Booster Vaccine Effectiveness

https://www.medi-paper.com/wp-content/uploads/2022/06/MPR-FOS-2022003_1918x1024.jpg 1024 1918 Kathlin Ambrose https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kathlin Ambrose2022-06-21 02:46:572022-07-13 05:48:31COVID-19 Antiviral Treatment and Booster Vaccine Effectiveness
Feasibility of Implementing Population-Wide Opt-Out HIV Testing Scheme

Feasibility of Implementing Population-Wide Opt-Out HIV Testing Scheme

https://www.medi-paper.com/wp-content/uploads/2022/06/HIV-cover-photo.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-06-20 07:49:562022-06-28 11:33:57Feasibility of Implementing Population-Wide Opt-Out HIV Testing Scheme
An Overview of the South African COVID-19 Subvariant Outbreak: How Serious is It?

An Overview of the South African COVID-19 Subvariant Outbreak

https://www.medi-paper.com/wp-content/uploads/2022/06/cover-photo-1918x1024-1.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-06-17 02:30:592022-06-28 11:55:35An Overview of the South African COVID-19 Subvariant Outbreak
COVID-19 Vaccinations in Adolescents and Children

COVID-19 Vaccinations in Adolescents and Children

https://www.medi-paper.com/wp-content/uploads/2022/05/COVID-19-Vaccinations-in-Adolescents-and-Children-scaled.jpg 1367 2560 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-05-30 07:01:232022-07-13 05:54:09COVID-19 Vaccinations in Adolescents and Children
Local Updates on COVID-19 Prevention and Treatment

Local Updates on COVID-19 Prevention and Treatment

https://www.medi-paper.com/wp-content/uploads/2022/05/Local-Updates-on-COVID-19-Prevention-and-Treatment-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-05-30 04:49:162022-05-31 11:25:18Local Updates on COVID-19 Prevention and Treatment
Tolerability of COVID-19 vaccines in patients with cancer

Tolerability of COVID-19 vaccines in patients with cancer

https://www.medi-paper.com/wp-content/uploads/2022/05/Tolerability-of-COVID-19-vaccines-in-patients-with-cancer-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-05-17 02:20:592022-05-17 05:46:03Tolerability of COVID-19 vaccines in patients with cancer
US and Chinese Studies Suggest More Severe Outcomes in COVID-19 Patients with Cancer

More Severe Outcomes in COVID-19 Patients with Cancer

https://www.medi-paper.com/wp-content/uploads/2022/05/US-and-Chinese-Studies-Suggest-More-Severe-Outcomes-in-COVID-19-Patients-with-Cancer-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-05-16 08:12:092022-05-17 05:46:03More Severe Outcomes in COVID-19 Patients with Cancer
COVID-19 vaccination safety and effectiveness for pregnant and lactating women

COVID-19 vaccination safety and effectiveness for pregnant and lactating women

https://www.medi-paper.com/wp-content/uploads/2022/05/COVID-19-vaccination-safety-and-effectiveness-for-pregnant-and-lactating-women-scaled.jpg 1367 2560 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-05-03 02:34:242022-05-17 05:46:03COVID-19 vaccination safety and effectiveness for pregnant and lactating women
Gut Microbiome: Predictor for COVID-19 Vaccine Response and Safety (CZ02 and BNT162b2)

Gut Microbiome: Predictor for COVID-19 Vaccine Response and Safety (CZ02 and BNT162b2)

https://www.medi-paper.com/wp-content/uploads/2022/04/Gut-Microbiome-Predictor-for-COVID-19-Vaccine-Response-and-Safety-CZ02-and-BNT162b2-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-04-29 10:30:502022-05-17 05:46:03Gut Microbiome: Predictor for COVID-19 Vaccine Response and Safety (CZ02 and BNT162b2)
US Study Suggests A Lesser-known COVID-19 Complication Diabetes Mellitus

US Study Suggests A Lesser-known COVID-19 Complication: Diabetes Mellitus

https://www.medi-paper.com/wp-content/uploads/2022/04/US-Study-Suggests-A-Lesser-known-COVID-19-Complication-Diabetes-Mellitus-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-04-29 05:47:272022-05-17 05:46:03US Study Suggests A Lesser-known COVID-19 Complication: Diabetes Mellitus
Vaccination Strategies and Management Against Omicron Outbreak

Vaccination Strategies and Management Against Omicron Outbreak

https://www.medi-paper.com/wp-content/uploads/2022/03/Vaccination-Strategies-and-Management-Against-Omicron-Outbreak.png 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-04-01 03:37:202022-05-17 05:46:03Vaccination Strategies and Management Against Omicron Outbreak
UK study_Infected adolescents are at higher risk of long COVID symptoms

UK study: Infected adolescents are at higher risk of long COVID symptoms

https://www.medi-paper.com/wp-content/uploads/2022/03/UK-study_Infected-adolescents-are-at-higher-risk-of-long-COVID-symptoms.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-03-01 07:20:182022-05-17 05:46:03UK study: Infected adolescents are at higher risk of long COVID symptoms
Antiviral Molnupiravir Associated with Reduced Risk of Hospitalisation or Death in COVID-19 Patients

Antiviral Molnupiravir Associated with Reduced Risk of Hospitalisation or Death in COVID-19 Patients

https://www.medi-paper.com/wp-content/uploads/2022/02/Antiviral-Molnupiravir-Associated-with-Reduced-Risk-of-Hospitalisation-or-Death-in-COVID-19-Patients.jpg 1024 1918 Chloe FUNG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Chloe FUNG2022-02-28 07:41:092022-05-17 05:46:03Antiviral Molnupiravir Associated with Reduced Risk of Hospitalisation or Death in COVID-19 Patients

Anti-TNF Therapy Correlated with Better Outcomes in IBD Patients with COVID-19

https://www.medi-paper.com/wp-content/uploads/2021/12/Anti-TNF-Therapy-Correlated-with-Better-Outcomes-in-IBD-Patients-with-COVID-19.jpg 1024 1917 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2021-12-20 12:58:472022-05-17 05:46:03Anti-TNF Therapy Correlated with Better Outcomes in IBD Patients with COVID-19

The use of COVID-19 vaccines in children and adolescents

https://www.medi-paper.com/wp-content/uploads/2021/12/The-use-of-COVID-19-vaccines-in-children-and-adolescents.jpg 1024 1917 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2021-12-16 11:53:112022-05-17 05:46:03The use of COVID-19 vaccines in children and adolescents
HPV-immunisation-in-UK-lowers-the-incidence-of-cervical-cancer-and-CIN3

HPV immunisation in UK lowers the incidence of cervical cancer and CIN3

https://www.medi-paper.com/wp-content/uploads/2021/12/HPV-immunisation-in-UK-lowers-the-incidence-of-cervical-cancer-and-CIN3.jpg 1024 1917 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2021-12-06 16:33:152022-02-20 10:34:01HPV immunisation in UK lowers the incidence of cervical cancer and CIN3
Combination-therapy-with-a-novel-agent-albuvirtide-in-hospitalised-AIDs-patients

Combination therapy with a novel agent, albuvirtide, in hospitalised AIDS patients

https://www.medi-paper.com/wp-content/uploads/2021/11/Combination-therapy-with-a-novel-agent-albuvirtide-in-hospitalised-AIDs-patients.jpg 1024 1917 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2021-11-03 23:59:572022-02-19 05:11:56Combination therapy with a novel agent, albuvirtide, in hospitalised AIDS patients
Pfizer-BioNTech-COVID-19-Vaccine-for-Ages-5-to-11-Years

BioNTech COVID-19 vaccine for ages 5 to 11 years – To jab or not to jab?

https://www.medi-paper.com/wp-content/uploads/2021/11/Pfizer-BioNTech-COVID-19-Vaccine-for-Ages-5-to-11-Years.jpg 1024 1917 Catalina FOK https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Catalina FOK2021-11-03 15:29:572022-07-13 05:55:25BioNTech COVID-19 vaccine for ages 5 to 11 years – To jab or not to jab?
Gender-related-differences-in-safety

Gender-related differences in safety after switching to BIC/TAF/FTC

https://www.medi-paper.com/wp-content/uploads/2021/11/Gender-related-differences-in-safety.jpg 1024 1917 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2021-11-03 14:49:542022-02-20 10:58:03Gender-related differences in safety after switching to BIC/TAF/FTC
Effect-of-HIV-infection-on-growth-and-bone-density-in-peripubertal-children-under-antiretroviral-therapy

Effect of HIV infection on growth and bone density in peripubertal children under antiretroviral therapy

https://www.medi-paper.com/wp-content/uploads/2021/07/Effect-of-HIV-infection-on-growth-and-bone-density-in-peripubertal-children-under-antiretroviral-therapy.webp 1024 1917 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2021-07-20 17:03:522022-02-23 07:54:14Effect of HIV infection on growth and bone density in peripubertal children under antiretroviral therapy
Safety-and-Immunogenicity-of-the-BNT162b2-mRNA-Covid-19-Vaccine-in-Patients-after-Allogeneic-HCT-or-CD19-based-CAR-T-therapy

Safety and Immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in Patients after Allogeneic HCT or CD19-based CAR-T therapy

https://www.medi-paper.com/wp-content/uploads/2021/07/Safety-and-Immunogenicity-of-the-BNT162b2-mRNA-Covid-19-Vaccine-in-Patients-after-Allogeneic-HCT-or-CD19-based-CAR-T-therapy.webp 1024 1917 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2021-07-20 16:38:402022-05-17 05:46:03Safety and Immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in Patients after Allogeneic HCT or CD19-based CAR-T therapy
Efficacy-and-safety-of-HIV-fusion-inhibitor-albuvirtide-in-treatment-experienced-patients-from-phase-3-TALENT-study

Efficacy and safety of HIV fusion inhibitor albuvirtide in treatment experienced patients from phase 3 TALENT study

https://www.medi-paper.com/wp-content/uploads/2021/07/Efficacy-and-safety-of-HIV-fusion-inhibitor-albuvirtide-in-treatment-experienced-patients-from-phase-3-TALENT-study.webp 1024 1917 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2021-07-15 15:04:522022-02-23 08:15:19Efficacy and safety of HIV fusion inhibitor albuvirtide in treatment experienced patients from phase 3 TALENT study
COVID-19-impacting-regular-patient-care-for-cardiovascular-diseases

COVID-19 impacting regular patient care for cardiovascular diseases

https://www.medi-paper.com/wp-content/uploads/2021/02/COVID-19-impacting-regular-patient-care-for-cardiovascular-diseases.jpg 1024 1918 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2021-02-17 11:52:282022-05-17 05:46:03COVID-19 impacting regular patient care for cardiovascular diseases
SARS-CoV-2-infection-in-children-and-an-increased-risk-of-thrombotic-microangiopathy

SARS-CoV-2 infection in children and an increased risk of thrombotic microangiopathy

https://www.medi-paper.com/wp-content/uploads/2021/02/SARS-CoV-2-infection-in-children-and-an-increased-risk-of-thrombotic-microangiopathy.jpg 1024 1918 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2021-02-10 15:41:562022-05-17 05:46:03SARS-CoV-2 infection in children and an increased risk of thrombotic microangiopathy
Toxic-vaccine-disinformation_有關疫苗的虛假信息

有關疫苗的虛假信息

https://www.medi-paper.com/wp-content/uploads/2021/01/Toxic-vaccine-disinformation_有關疫苗的虛假信息.jpg 1024 1819 Dr Siddharth Sridhar https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Dr Siddharth Sridhar2021-01-11 18:28:422022-05-17 05:46:04有關疫苗的虛假信息
Evidence-of-SARS-CoV2-in-heart-cells

Evidence of SARS-CoV2 in heart cells

https://www.medi-paper.com/wp-content/uploads/2020/09/Evidence-of-SARS-CoV2-in-heart-cells.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-22 10:19:272022-05-17 05:46:04Evidence of SARS-CoV2 in heart cells
triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia

Triple combination effective for hospital- and ventilator-acquired pneumonia

https://www.medi-paper.com/wp-content/uploads/2020/09/triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-10 11:04:232022-02-24 01:58:40Triple combination effective for hospital- and ventilator-acquired pneumonia
risk-of-thrombosis-with-sars-cov-2-infection

Risk of thrombosis with SARS-CoV-2 infection

https://www.medi-paper.com/wp-content/uploads/2020/08/risk-of-thrombosis-with-sars-cov-2-infection.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-27 16:33:072022-05-17 05:46:04Risk of thrombosis with SARS-CoV-2 infection
no-difference-in-kidney-transplantation-outcomes-for-HIV-positive-recipients-regardless-of-donor-HIV-status

No difference in kidney transplantation outcomes for HIV-positive recipients regardless of donor HIV status

https://www.medi-paper.com/wp-content/uploads/2020/08/no-difference-in-kidney-transplantation-outcomes-for-HIV-positive-recipients-regardless-of-donor-HIV-status.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-25 10:15:352022-02-24 03:56:17No difference in kidney transplantation outcomes for HIV-positive recipients regardless of donor HIV status
residual-risk-of-hepatocellular-carcinoma-in-older-hepatitis-c-patients-even-after-viral-clearance

Residual risk of hepatocellular carcinoma in older Hepatitis C patients even after viral clearance

https://www.medi-paper.com/wp-content/uploads/2020/08/residual-risk-of-hepatocellular-carcinoma-in-older-hepatitis-c-patients-even-after-viral-clearance.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 16:18:002022-02-24 03:58:03Residual risk of hepatocellular carcinoma in older Hepatitis C patients even after viral clearance
potential-protective-effects-of-the-influenza-vaccine-on-cardiovascular-outcomes-in-high-risk-populations

Potential protective effects of the influenza vaccine on cardiovascular outcomes in high-risk populations

https://www.medi-paper.com/wp-content/uploads/2020/08/potential-protective-effects-of-the-influenza-vaccine-on-cardiovascular-outcomes-in-high-risk-populations.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 15:28:132022-02-24 03:59:44Potential protective effects of the influenza vaccine on cardiovascular outcomes in high-risk populations
updated-human-papillomavirus-vaccination-and-testing-recommendations-from-the-american-cancer-society

Updated human papillomavirus vaccination and testing recommendations from the American Cancer Society

https://www.medi-paper.com/wp-content/uploads/2020/08/updated-human-papillomavirus-vaccination-and-testing-recommendations-from-the-american-cancer-society.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 14:41:322022-02-24 04:10:20Updated human papillomavirus vaccination and testing recommendations from the American Cancer Society
interim-results-of-a-Phase-2b-3-trial-investigating-a-long-acting-injectable-of-cabotegravir-for-pre-exposure-prophylaxis-of-HIV

Interim results of a Phase 2b/3 trial investigating a long-acting injectable of cabotegravir for pre-exposure prophylaxis of HIV

https://www.medi-paper.com/wp-content/uploads/2020/08/interim-results-of-a-Phase-2b-3-trial-investigating-a-long-acting-injectable-of-cabotegravir-for-pre-exposure-prophylaxis-of-HIV.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-04 14:44:162022-02-24 04:09:24Interim results of a Phase 2b/3 trial investigating a long-acting injectable of cabotegravir for pre-exposure prophylaxis of HIV
comparison-of-the-metabolic-changes-from-the-tango-trial-a-post-hoc-analysis

Comparison of the metabolic changes from the TANGO trial: a post-hoc analysis

https://www.medi-paper.com/wp-content/uploads/2020/08/comparison-of-the-metabolic-changes-from-the-tango-trial-a-post-hoc-analysis.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-04 14:02:232022-02-24 04:14:25Comparison of the metabolic changes from the TANGO trial: a post-hoc analysis
Carboplatin-plus-paclitaxel-to-be-the-new-standard-of-care-for-anal-cancer

Carboplatin plus paclitaxel to be the new standard of care for anal cancer

https://www.medi-paper.com/wp-content/uploads/2020/07/Carboplatin-plus-paclitaxel-to-be-the-new-standard-of-care-for-anal-cancer.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-07-10 17:24:482022-02-24 04:17:57Carboplatin plus paclitaxel to be the new standard of care for anal cancer
Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia-2019新型冠狀病毒肺炎患者的臨床特徵-e1581435553798

更新: Covid-19患者的臨床特徵

https://www.medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia-2019新型冠狀病毒肺炎患者的臨床特徵-e1581435553798.webp 540 720 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-26 15:24:412022-05-17 05:46:03更新: Covid-19患者的臨床特徵
Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia-WARS-Wuhan-Pneumonia-coronavirus-outbreak-sars-mers-e1581490460128

Updated: Clinical characteristics of patients with COVID-19

https://www.medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia-WARS-Wuhan-Pneumonia-coronavirus-outbreak-sars-mers-e1581490460128.webp 470 987 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-26 15:23:392022-05-17 05:46:03Updated: Clinical characteristics of patients with COVID-19
Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-開始-結束

開始? 結束?

https://www.medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-開始-結束.webp 750 1000 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-22 23:07:372022-05-17 05:46:04開始? 結束?
Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-in-Hong-Kong-the-end-of-the-beginning-

COVID-19 in Hong Kong: the end of the beginning?

https://www.medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-in-Hong-Kong-the-end-of-the-beginning-.jpg 760 1000 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-22 13:48:352022-05-17 05:46:03COVID-19 in Hong Kong: the end of the beginning?
Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-How-do-People-get-Covid-19-in-Hong-Kong-在本港,人們如何感染Covid-19

How do people get COVID-19 in Hong Kong

https://www.medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-How-do-People-get-Covid-19-in-Hong-Kong-在本港,人們如何感染Covid-19.webp 920 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-20 21:45:582022-05-17 05:46:03How do people get COVID-19 in Hong Kong
Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-How-do-People-get-Covid-19-in-Hong-Kong-在本港,人們如何感染Covid-19

在本港,人們如何感染Covid-19?

https://www.medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-How-do-People-get-Covid-19-in-Hong-Kong-在本港,人們如何感染Covid-19.webp 920 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-20 21:45:452022-05-17 05:46:03在本港,人們如何感染Covid-19?
Dr-Siddharth-Sridhar-2019-nCoV-Summary-of-the-situation-in-HK-2019-nCoV在本港的概況

2019-nCoV – Summary of the situation in HK as of Feb 6, 2020

https://www.medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-Summary-of-the-situation-in-HK-2019-nCoV在本港的概況.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-07 00:31:582022-02-24 07:57:172019-nCoV – Summary of the situation in HK as of Feb 6, 2020
Dr-Siddharth-Sridhar-2019-nCoV-Summary-of-the-situation-in-HK-2019-nCoV在本港的概況

2019-nCoV在本港的概況(截至2020年2月6日)

https://www.medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-Summary-of-the-situation-in-HK-2019-nCoV在本港的概況.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-07 00:31:112022-02-24 08:01:172019-nCoV在本港的概況(截至2020年2月6日)
Dr-Sridhar-Siddharth-How-infectious-is-novel-coronavirus-2019-nCoV-新型冠狀病毒-2019-nCoV-的傳染性有多高

新型冠狀病毒(2019-nCoV)的傳染性有多高?

https://www.medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-How-infectious-is-novel-coronavirus-2019-nCoV-新型冠狀病毒-2019-nCoV-的傳染性有多高.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-04 00:49:132022-02-24 08:03:13新型冠狀病毒(2019-nCoV)的傳染性有多高?
Dr-Sridhar-Siddharth-How-infectious-is-novel-coronavirus-2019-nCoV-新型冠狀病毒-2019-nCoV-的傳染性有多高

How infectious is novel coronavirus (2019-nCoV)

https://www.medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-How-infectious-is-novel-coronavirus-2019-nCoV-新型冠狀病毒-2019-nCoV-的傳染性有多高.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-03 22:33:562022-02-24 08:04:46How infectious is novel coronavirus (2019-nCoV)
Dr-Siddharth-Sridhar-How-stable-are-coronaviruses-in-the-environment-2019-nCoV-冠狀病毒在環境中的穩定性

2019-nCoV: how stable are coronaviruses in the environment?

https://www.medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-How-stable-are-coronaviruses-in-the-environment-2019-nCoV-冠狀病毒在環境中的穩定性.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-02 19:45:432022-02-24 08:07:252019-nCoV: how stable are coronaviruses in the environment?
Dr-Siddharth-Sridhar-How-stable-are-coronaviruses-in-the-environment-2019-nCoV-冠狀病毒在環境中的穩定性

2019-nCoV: 冠狀病毒在環境中的穩定性

https://www.medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-How-stable-are-coronaviruses-in-the-environment-2019-nCoV-冠狀病毒在環境中的穩定性.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-02 19:29:372022-02-24 08:09:022019-nCoV: 冠狀病毒在環境中的穩定性
Dr-Sridhar-Siddharth-Who-gets-severe-novel-coronavirus-2019-nCoV-infection

Who gets severe novel coronavirus (2019-nCoV) infection?

https://www.medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Who-gets-severe-novel-coronavirus-2019-nCoV-infection.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-01 23:45:262022-02-24 08:10:40Who gets severe novel coronavirus (2019-nCoV) infection?
Dr-Sridhar-Siddharth-Who-gets-severe-novel-coronavirus-2019-nCoV-infection

誰受到 2019-nCoV嚴重感染?

https://www.medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Who-gets-severe-novel-coronavirus-2019-nCoV-infection.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-01 23:27:182022-02-24 08:15:19誰受到 2019-nCoV嚴重感染?
Previous Previous Previous Next Next Next
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

© Copyright 2022 MediPaper Medical Communications Ltd. – Monkeypox Virus: How Likely is a Local Outbreak?

Categories

Categories

Newsletter


 [‘mediPr] | MediPaper Healthcare Writers | Digital Medical Marketing | Medical Writing Solutions 醫學寫作 | Medical Writing Quote | Medical Writing Portfolio | Medical Writer Hong Kong 醫學作家香港 | Hire Healthcare Writers Hong Kong | Contact our Medical Writer Agency | MediPaper Health News | CORTiX AI for Medical Science | Dub-Dub Subtitle Generation
© 2016-2026 MediPaper Medical Communications Ltd. | Website by [’mediPr] Sydney | Singapore | Hong Kong | 醫學作家香港 | Privacy Policy | Cookie Policy
  • Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
Link to: Local Updates on COVID-19 Prevention and Treatment Link to: Local Updates on COVID-19 Prevention and Treatment Local Updates on COVID-19 Prevention and TreatmentLocal Updates on COVID-19 Prevention and Treatment Link to: COVID-19 Vaccinations in Adolescents and Children Link to: COVID-19 Vaccinations in Adolescents and Children COVID-19 Vaccinations in Adolescents and ChildrenCOVID-19 Vaccinations in Adolescents and Children
Scroll to top Scroll to top Scroll to top

This site uses cookies to improve your experience. By continuing to browse the site, you are agreeing to our use of cookies.

OKPrivacy Settings×

Cookies and Privacy on medi-paper.com



Cookie Policy

How MediPaper uses cookies is explained in our Cookie Policy

Privacy Policy

Read MediPaper's Privacy Policy

Google Analytics cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Vimeo and Youtube video embeds:

5
Accept settingsHide notification only